Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bevacizumab|DRUG: vinorelbine|DRUG: trastuzumab
Sponsor: Harold J. Burstein, MD, PhD
Collaborators: Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Genentech, Inc.|New Hampshire Oncology-Hematology PA|Lowell General Hospital|Hartford Hospital